Top news of the week: 29.09.2020.

#COVID19 #lifesciences #COVID #treatment #biotechnology #vaccine #coronavirus #biospace #pharmaceuticals #pandemic

Companies And Industries

On Sep 28, 2020
@BiotechWorld shared
South Korean exosome biotech Ilias Biologics nabs $20M B round https://t.co/wd0Ld3u5eb https://t.co/sV9jlsF2qv
Open

South Korean exosome biotech Ilias Biologics nabs $20M B round

South Korean exosome biotech Ilias Biologics nabs $20M B round

Preclinical inflammatory disease biotech Ilias Biologics has grabbed a $20.6 million funding round as it eyes a 2021 human test of its leading candidate ILB-202.

On Sep 22, 2020
@Amgen shared
RT @AmgenFoundation: Thirty years ago, Amgen scientists came together with local high school teachers to transform how #science is introduced, experienced, and accessed all over the world. Happy anniversary, @ABEProgOffice 🎂🎈🎉 #ScienceMadePossible https://t.co/NmK6PAzCnT https://t.co/DYcCERGNHI
Open

Amgen Foundation Commits $16.4M to the Amgen Biotech Experience

Amgen Foundation Commits $16.4M to the Amgen Biotech Experience

The announcement comes on the 30th Anniversary of the ABE program, which has successfully delivered hands on biotechnology labs to nearly 850,000 students.

On Sep 25, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: September 25 #biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/lkll4ZIgMf
Open

Biopharma Update on the Novel Coronavirus: September 25

Biopharma Update on the Novel Coronavirus: September 25

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 25, 2020.

On Sep 28, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: September 28 #biospace #lifesciences #biotechnology #pharmaceuticals #clinicaltrials #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/5rN7SnG0V4
Open

Biopharma Update on the Novel Coronavirus: September 28

Biopharma Update on the Novel Coronavirus: September 28

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 28, 2020.

On Sep 24, 2020
@CellCultureDish shared
Flexible Platform Solutions Overcome Vaccine Production Challenges - https://t.co/RA4RsvvGZL
Open

Flexible Platform Solutions Overcome Vaccine Production Challenges

Flexible Platform Solutions Overcome Vaccine Production Challenges

A Guest Article by Pall Biotech The team from Pall Biotech explores the challenges of vaccine development and how they can be overcome by applying a quality by design (QbD) …

On Sep 24, 2020
@Labiotech_eu shared
Imperative to most clinical studies is #immune cell monitoring. But it requires viable cells. The problem: sample logistics can be challenging! 🧗‍♀️#biotech https://t.co/4mKz4joY3b @Precision4Med
Open

How a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring

How a Berlin-Based Biotech Pushes the Limits of Immune Cell Monitoring

Immune cell monitoring is imperative for almost any clinical study. The problem: Current procedures require viable cells, a demand often torpedoed by sample logistics. What do cancer, ...

On Sep 24, 2020
@GENbio shared
“Debugging a problem in the therapeutics space is very costly and disruptive, because the cause is often a mystery,” explains [email protected], PhD, CEO and founder of [email protected]_io. Personalized Medicine Manufacturing Needs “Debugging Tools”. Learn more: https://t.co/nwDej3qeEv https://t.co/22jQObB7Ea
Open

Personalized Medicine Manufacturing Needs “Debugging Tools”

Personalized Medicine Manufacturing Needs “Debugging Tools”

Machine learning/AI and automation can help researchers and manufacturers identify where a problem lies.

On Sep 25, 2020
@illumina shared
Looking forward to @Ashley_VanZ sharing about #covid19 & #genomics with K12 educators in an upcoming speaker series (Oct 21). @BiocomInstitute will be sharing the endless ways to bring DNA into classrooms. Educators register here https://t.co/3HX6BqJ1Sg #stem #ngss https://t.co/yNsNBkfcsT
Open

The Life Science Industry Speaker Series for Educators Ashley Van Zeeland, Illumina VP of Product Integration & Customer Collaboration

The Life Science Industry Speaker Series for Educators Ashley Van Zeeland, Illumina VP of Product Integration & Customer Collaboration

The Life Science Industry Speaker Series for Educators Ashley Van Zeeland, Illumina VP of Product Integration & Customer Collaboration